首页> 外文期刊>JAMA: the Journal of the American Medical Association >Randomized Trials in Hemodialysis Patients
【24h】

Randomized Trials in Hemodialysis Patients

机译:血液透析患者的随机试验

获取原文
获取原文并翻译 | 示例
       

摘要

HEMODIALYSIS REQUIRES A RELIABLE CONDUIT TO transport blood from the patient to the dialysis apparatus and back again, which is usually termed "vascular access." Establishing and maintaining vascular access is time-consuming, difficult, and expensive?access creation and complications are the most common causes of hospital admissions in patients with end-stage renal disease,1 at an estimated annual cost of more than Dollars 1 billion in the United States alone.2 Accordingly, vascular access has been termed the "Achilles' heel" of hemodialysis# #1 Dollars 1001N200307007Dollars 1200
机译:血液透析需要一种可靠的方法来将血液从患者输送到透析设备,然后再输送回去,这通常被称为“血管通路”。建立和维持血管通路是耗时,困难且昂贵的?通路形成和并发症是终末期肾病患者住院的最常见原因1,估计每年的费用超过10亿美元。仅在美国。2因此,血管通路被称为血液透析的“致命弱点”#1美元1001N200307007美元1200

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号